FDA Approved HIV Prevention Shot Yeztugo: Twice-Yearly Injection Revolutionizes PrEP in 2025
FDA approved HIV prevention shot Yeztugo (lenacapavir) in June 2025 as the first twice-yearly injection for HIV PrEP, offering nearly 100% efficacy and transforming public health strategies globally. . 🧬 US FDA Approves Twice‑Yearly HIV Prevention Shot On June 18, 2025, the U.S. Food and Drug Administration (FDA) granted approval to lenacapavir, branded as Yeztugo,…